Researchers at The Institute of Cancer Research, London, working with Merck KGaA, have developed the first potent small-molecule inhibitors of DHX8, an enzyme involved in pre-mRNA splicing. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results